D'Incà R - Search Results

1

S100B as a new fecal biomarker of inflammatory bowel diseases.

Di Liddo R, Piccione M, Schrenk S, Dal Magro C, Cosma C, Padoan A, Contran N, Scapellato ML, Pagetta A, Romano Spica V, Conconi MT, Parnigotto PP, D'Incà R, Michetti F. Di Liddo R, et al. Eur Rev Med Pharmacol Sci. 2020 Jan;24(1):323-332. doi: 10.26355/eurrev_202001_19929. Eur Rev Med Pharmacol Sci. 2020. PMID: 31957846 Free article.

2

Serum human cartilage glycoprotein 39 as a marker of arthritis associated with inflammatory bowel disease.

Punzi L, Podswiadek M, D'Incà R, Zaninotto M, Bernardi D, Plebani M, Sturniolo GC. Punzi L, et al. Ann Rheum Dis. 2003 Dec;62(12):1224-6. doi: 10.1136/ard.2002.004408. Ann Rheum Dis. 2003. PMID: 14644865 Free PMC article. Clinical Trial.

3

Calprotectin and lactoferrin in the assessment of intestinal inflammation and organic disease.

D'Incà R, Dal Pont E, Di Leo V, Ferronato A, Fries W, Vettorato MG, Martines D, Sturniolo GC. D'Incà R, et al. Int J Colorectal Dis. 2007 Apr;22(4):429-37. doi: 10.1007/s00384-006-0159-9. Epub 2006 Jul 13. Int J Colorectal Dis. 2007. PMID: 16838143

4

Enzymes in feces: useful markers of chronic inflammatory bowel disease.

Angriman I, Scarpa M, D'Incà R, Basso D, Ruffolo C, Polese L, Sturniolo GC, D'Amico DF, Plebani M. Angriman I, et al. Clin Chim Acta. 2007 May;381(1):63-8. doi: 10.1016/j.cca.2007.02.025. Epub 2007 Feb 21. Clin Chim Acta. 2007. PMID: 17368600 Review.

5

Can calprotectin predict relapse risk in inflammatory bowel disease?

D'Incà R, Dal Pont E, Di Leo V, Benazzato L, Martinato M, Lamboglia F, Oliva L, Sturniolo GC. D'Incà R, et al. Am J Gastroenterol. 2008 Aug;103(8):2007-14. doi: 10.1111/j.1572-0241.2008.01870.x. Am J Gastroenterol. 2008. PMID: 18802997 Clinical Trial.

6

Articular manifestations in inflammatory bowel disease patients: a prospective study.

D'Incà R, Podswiadek M, Ferronato A, Punzi L, Salvagnini M, Sturniolo GC. D'Incà R, et al. Dig Liver Dis. 2009 Aug;41(8):565-9. doi: 10.1016/j.dld.2009.01.013. Epub 2009 Mar 10. Dig Liver Dis. 2009. PMID: 19278908

7

Clinical utility of calprotectin and lactoferrin as markers of inflammation in patients with inflammatory bowel disease.

Caccaro R, D'Incá R, Sturniolo GC. Caccaro R, et al. Expert Rev Clin Immunol. 2010 Jul;6(4):551-8. doi: 10.1586/eci.10.26. Expert Rev Clin Immunol. 2010. PMID: 20594128

8

Dysplasia in inflammatory bowel diseases.

Mescoli C, Albertoni L, D'incá R, Rugge M. Mescoli C, et al. Dig Liver Dis. 2013 Mar;45(3):186-94. doi: 10.1016/j.dld.2012.07.013. Epub 2012 Sep 10. Dig Liver Dis. 2013. PMID: 22974564 Review.

9

Clinical utility of calprotectin and lactoferrin in patients with inflammatory bowel disease: is there something new from the literature?

Caccaro R, D'Incà R, Pathak S, Sturniolo GC. Caccaro R, et al. Expert Rev Clin Immunol. 2012 Aug;8(6):579-85. doi: 10.1586/eci.12.50. Expert Rev Clin Immunol. 2012. PMID: 22992152 Review.

10

Umbilical cord mesenchymal stem cells modulate dextran sulfate sodium induced acute colitis in immunodeficient mice.

Banerjee A, Bizzaro D, Burra P, Di Liddo R, Pathak S, Arcidiacono D, Cappon A, Bo P, Conconi MT, Crescenzi M, Pinna CM, Parnigotto PP, Alison MR, Sturniolo GC, D'Incà R, Russo FP. Banerjee A, et al. Stem Cell Res Ther. 2015 Apr 16;6(1):79. doi: 10.1186/s13287-015-0073-6. Stem Cell Res Ther. 2015. PMID: 25890182 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

288 results

Search Page